We would love to hear your thoughts about our site and services, please take our survey here.
This is one thing that may impact the EXEC Team Smart:
“Such deferred performance related consideration, if any, shall be satisfied annually in the form of Deferred Consideration Shares issued at a price equivalent to the volume-weighted average closing mid-market share price over the 30 trading days immediately preceding the first day on which the financial results for the prior year with reference to which such deferred performance related consideration will be calculated are publicly released.”
2022 books close in 17 days!
Informative post JD and I concur. A long while back I think I mentioned a number of $8M + for Break Even, and that was based on the previous (& better)GM. So for me the focus must be on PROFITABLE growth. Sales without sufficient margin is not a long term strategy for the company or its customers.
AJP, I have to say, that is a brilliant find. I don’t know what, if anything, may result from it, but our company is on the same platform as BASF and I’m a shareholder in both (with small positions) which means I’m a lookin’ an’ a likin’
Thordon great work. You are a sleuth among sleuths thank you for your research and dedication to a tiny mCap company which has been flying its green credentials FLAG - some might say too feebly - or too tardily- over the past number of years, but we are on the cusp of something special. When I say „we“ credit must go to Yvon Durant - the company scientist, engineer, visionary, and IP/Patent Protector who has delivered a rock solid foundation for us.
All good AJP. Just crossing fingers & toes and sitting on my hands waiting patiently. Been looking for IA November import data, but no joy yet - unlike your wipes sleuthing!
The executive team are due one last “payday” from their current incentive programme which is based on released 2022 results and amount of revenue growth achieved - so we may find big news items will be released around that time also.
Any thoughts on this Thordon? (from 2014)
https://www.winfieldunitedcropnutrients.com/WUCN/media/WF_Crop_Nutrients_Images/Pdf/CN_SDS/SDS-AVAIL-Liquid-Verdesian.pdf
Thanks
DB
7ver. As you say: Bring on next week and the week after and the week after that and so on - but that all depends if we align ourselves with the Itaconix revenue growth curve - which I do - altbeit delayed!
Thanks Thordon. If I was ITX CEO, with an announcement like that, where my strategic customer Nouryon, had just acquired an Agri-Fertiliser business with Green credentials, I would be straight on the phone to set up a 3-way meeting. So short answer, yes, I hope there is a good fit with upside for ITACONIX.
20p second half of ‘23 would be my take, based on growing input volumes, growing revenues, break-even being reached, product roadmaps continuing to deliver, strategic partnerships. Until then, I think there will enough to keep the share price ticking along and not forgetting a lower share price until release of 2022 results is a better share incentive earner for the management team - who like many of us are in for the long term. Just my view!
Yes, don’t post much myself there Thordon - some things too hard!
Staying with the agricultural theme, though, this is relevant:
https://www.nouryon.com/news-and-events/news-overview/2022/nouryon-to-acquire-adob-fertilizer/
Hi all this company and share can cause some frustration, as seen in a few recent posts. So, getting back to the knitting, as it were, when do we think Break Even is going to happen? After which, it is presumably „game-on“ and a trajectory of increasing profitability. We drift where are until B.E. is clearly viewed. My view is 2023.
I‘ve just found time to have a quick run through the presentation from the last update and there is a LOT of great things in the pipeline. 2023 is the year of delivery for me - been saying that for a while now - and if the management team can hold on to the timelines given for their other pipeline projects, then we are really off to the races. The presentation - and it is the nature of Itaconix we have come to know - feels underplayed (good!) as I don’t like overpromising. On that basis I wouldn’t rule out one or two present surprises appearing - but probably not til 2023. Just my meanderings!
https://www.investormeetcompany.com/investor/meeting/final-results-31/presentation